ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy

Molecular Therapy - United States
doi 10.1038/mt.2011.155
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Adenosine A2A Receptor Antagonists Act at the Hyperoxic Phase to Confer Protection Against Retinopathy

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2018English

Olmesartan Improves the Formation of Impaired Epcs and Renal Degeneration Through Activation of the ACE2/Ang-(1–7)/Mas Receptor Axis in SHRS

Journal of Hypertension- Open Access
2013English

Enhanced Expression of Ang-(1-7) During Pregnancy

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2004English

Role of the ACE2‑Ang‑(1‑7)‑Mas Axis in Blood Pressure Regulation and Its Potential as an Antihypertensive in Functional Foods (Review)

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Predicting Development of Proliferative Diabetic Retinopathy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2012English

Do Thiazide Diuretics Confer Specific Protection Against Strokes?

Archives of Internal Medicine
2003English

Decidualized Pseudopregnant Rat Uterus Shows Marked Reduction in Ang II and Ang-(1-7) Levels

Placenta
GynecologyReproductive MedicineDevelopmental BiologyObstetrics
2012English

Mitochondrial Biogenesis and the Development of Diabetic Retinopathy

Free Radical Biology and Medicine
BiochemistryPhysiology
2011English

The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)

Physiological Reviews
MedicinePhysiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy